Oxford, United Kingdom · Founded 2017 · Privately Held (backing)
Developer of an artificial intelligence-based cardiovascular diagnostic technology designed to detect heart failure and amyloidosis. Ultromics is based in Oxford, United Kingdom and was founded in 2017. Its last reported valuation was $131 million in Jul 2025. It has raised $136 million.
Last reported valuation
$131.0M
Oct 2026
Priced at
—
Total raised
$135.8M
Last round
—
Team — not yet on record
No current team members for Ultromics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Ultromics with a free account
·The complete investor list: 27 names
·Watch Ultromics: the Monday email on marks, rounds and moves
